• Afhalen na 1 uur in een winkel met voorraad
  • Gratis thuislevering in België vanaf € 30
  • Ruim aanbod met 7 miljoen producten
  • Afhalen na 1 uur in een winkel met voorraad
  • Gratis thuislevering in België vanaf € 30
  • Ruim aanbod met 7 miljoen producten
  1. Boeken
  2. Non-fictie
  3. Wetenschap
  4. Geneeskunde
  5. Interne geneeskunde
  6. Screening for Biological Response Modifiers: Methods and Rationale

Screening for Biological Response Modifiers: Methods and Rationale

James E Talmadge, Isaiah J Fidler, R K Oldham
Paperback | Engels | Developments in Oncology | nr. 29
€ 125,95
+ 251 punten
Uitvoering
Levering 1 à 2 weken
Eenvoudig bestellen
Veilig betalen
Gratis thuislevering vanaf € 30 (via bpost)
Gratis levering in je Standaard Boekhandel

Omschrijving

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).

Specificaties

Betrokkenen

Auteur(s):
Uitgeverij:

Inhoud

Aantal bladzijden:
194
Taal:
Engels
Reeks:
Reeksnummer:
nr. 29

Eigenschappen

Productcode (EAN):
9781461296249
Verschijningsdatum:
18/11/2011
Uitvoering:
Paperback
Formaat:
Trade paperback (VS)
Afmetingen:
156 mm x 234 mm
Gewicht:
303 g
Standaard Boekhandel

Alleen bij Standaard Boekhandel

+ 251 punten op je klantenkaart van Standaard Boekhandel
E-BOOK ACTIE

Tot meer dan 50% korting

op een selectie e-books
E-BOOK ACTIE
E-book kortingen
Standaard Boekhandel

Beoordelingen

We publiceren alleen reviews die voldoen aan de voorwaarden voor reviews. Bekijk onze voorwaarden voor reviews.